Literature DB >> 32065301

Interchangeability of the EQ-5D and the SF-6D, and comparison of their psychometric properties in a spinal postoperative Spanish population.

Carmen Selva-Sevilla1, Paula Ferrara2, Manuel Gerónimo-Pardo3.   

Abstract

OBJECTIVE: EuroQol-5D (EQ-5D) and Short-Form Six-Dimensions (SF-6D) are widely used to calculate quality-adjusted life-years in cost-utility analysis. The choice of the instrument could influence the results of cost-utility analysis. Our objective was to compare the psychometric properties of the EQ-5D and SF-6D in a postoperative Spanish population, as well as assess their interchangeability in a cost-utility analysis.
DESIGN: Ambispective study.
SETTING: Tertiary public hospital. PARTICIPANTS: 275 Spanish patients who had undergone surgery for lumbar disc herniation. INTERVENTION(S): Patients completed EQ-5D-3L and Short-Form 36 (SF-36v2) questionnaires. Internal consistency, floor and ceiling effects, agreement, and construct validity (convergent validity, including dimension-to-dimension correlations, and "known groups" validity) were assessed. The Spanish tariffs were applied. MAIN OUTCOME MEASURE(S): Cronbach's α coefficient, Spearman's rank correlation coefficient, Lin's concordance correlation coefficient, intraclass correlation coefficient and Bland-Altman plot.
RESULTS: Main findings were: (a) lack of agreement between EQ-5D and SF-6D utilities (Lin's concordance correlation coefficient: 0.664 [95% CI: 0.600-0.720]; the Bland-Altman plot showed a mean difference of 0.0835 and wide limits of agreement [- 0.2602-0.4272]). (b) Lack of correlation between domains that theoretically measure similar aspects of quality of life, with the exception of "pain" domain.
CONCLUSIONS: The preference-based EQ-5D and SF-6D instruments showed valid psychometric properties to assess generic outcome in a Spanish population who had undergone surgery for lumbar disc herniation; however, utility scores derived from the measures were different. Thus, these two instruments cannot be used interchangeably to perform a cost-utility analysis, and they should both be included in sensitivity analyses.

Entities:  

Keywords:  EuroQoL-5D (EQ-5D); Interchangeability; Patient-reported outcome measure; Psychometric properties; Short-Form Six-Dimensions (SF-6D); Spanish version

Mesh:

Year:  2020        PMID: 32065301     DOI: 10.1007/s10198-020-01161-4

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  38 in total

1.  The estimation of a preference-based measure of health from the SF-36.

Authors:  John Brazier; Jennifer Roberts; Mark Deverill
Journal:  J Health Econ       Date:  2002-03       Impact factor: 3.883

2.  How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis?

Authors:  Annelies Boonen; Désirée van der Heijde; Robert Landewé; Astrid van Tubergen; Herman Mielants; Maxime Dougados; Sjef van der Linden
Journal:  Ann Rheum Dis       Date:  2007-01-09       Impact factor: 19.103

3.  Measuring preferences for cost-utility analysis: how choice of method may influence decision-making.

Authors:  Christine M McDonough; Anna N A Tosteson
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

4.  SF-6D versus EQ-5D: reasons for differences in utility scores and impact on reported cost-utility.

Authors:  Richard Grieve; Marina Grishchenko; John Cairns
Journal:  Eur J Health Econ       Date:  2008-03-09

5.  Comparing SF-6D and EQ-5D utilities across groups differing in health status.

Authors:  Nick Kontodimopoulos; Evelina Pappa; Angelos A Papadopoulos; Yannis Tountas; Dimitris Niakas
Journal:  Qual Life Res       Date:  2008-11-29       Impact factor: 4.147

6.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

7.  An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.

Authors:  Stavros Petrou; Christine Hockley
Journal:  Health Econ       Date:  2005-11       Impact factor: 3.046

8.  A comparison of the performance of the EQ-5D and SF-6D for individuals aged >or= 45 years.

Authors:  Garry R Barton; Tracey H Sach; Anthony J Avery; Claire Jenkinson; Michael Doherty; David K Whynes; Kenneth R Muir
Journal:  Health Econ       Date:  2008-07       Impact factor: 3.046

9.  The impact of differences in EQ-5D and SF-6D utility scores on the acceptability of cost-utility ratios: results across five trial-based cost-utility studies.

Authors:  Manuela Joore; Danielle Brunenberg; Patricia Nelemans; Emiel Wouters; Petra Kuijpers; Adriaan Honig; Danielle Willems; Peter de Leeuw; Johan Severens; Annelies Boonen
Journal:  Value Health       Date:  2009-10-29       Impact factor: 5.725

10.  Comparing cost-utility estimates: does the choice of EQ-5D or SF-6D matter?

Authors:  Tracey H Sach; Garry R Barton; Claire Jenkinson; Michael Doherty; Anthony J Avery; Kenneth R Muir
Journal:  Med Care       Date:  2009-08       Impact factor: 2.983

View more
  2 in total

Review 1.  Shoulder conditions and health related quality of life and utility: a current concepts review.

Authors:  Christian Shigley; Andrew Green
Journal:  JSES Int       Date:  2021-11-20

2.  Comparison of the measurement properties of SF-6Dv2 and EQ-5D-5L in a Chinese population health survey.

Authors:  Shitong Xie; Dingyao Wang; Jing Wu; Chunyu Liu; Wenchen Jiang
Journal:  Health Qual Life Outcomes       Date:  2022-06-16       Impact factor: 3.077

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.